Skip to main content
Erschienen in: Journal of Neurology 6/2011

01.06.2011 | Original Communication

Volume reduction in subcortical regions according to severity of Alzheimer’s disease

verfasst von: Jee Hoon Roh, Anqi Qiu, Sang Won Seo, Hock Wei Soon, Jong Hun Kim, Geon Ha Kim, Min-Jeong Kim, Jong-Min Lee, Duk L. Na

Erschienen in: Journal of Neurology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

We investigated whether there exists a hierarchical vulnerability of subcortical structures with respect to the severity of Alzheimer’s disease (AD). A total of 236 subjects (179 with AD and 57 with normal cognition) underwent 1.5-T magnetic resonance (MR) imaging. The volumes of the five subcortical structures (amygdala, thalamus, putamen, globus pallidus, and caudate nucleus) and hippocampus were analyzed using a large deformation diffeomorphic metric mapping algorithm. The volume changes were evaluated according to the Clinical Dementia Rating (CDR). Correlation between the volumes of the subcortical structures and scores of the cognitive domain-specific neuropsychological tests were evaluated. Volume loss of the amygdala occurred even in the very mild stage of AD (CDR 0.5), as did volume loss in the hippocampus. Similar reductions in volume occurred in the thalamus and putamen, however during the mild (CDR 1) and moderate (CDR 2) stages of AD, respectively. The globus pallidus and caudate nucleus remained devoid of changes until the moderate stage of AD (p < 0.01). Volume loss in those subcortical structures correlated with the neuropsychological test scores (p < 0.01). Our results suggest that there is a hierarchical vulnerability in subcortical structures according to the clinical severity of AD and that subcortical volume reductions correlate with cognitive impairment.
Literatur
1.
Zurück zum Zitat Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL (2010) Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in Dementia patients. J Korean Med Sci 25:1071–1076PubMedCrossRef Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL (2010) Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in Dementia patients. J Korean Med Sci 25:1071–1076PubMedCrossRef
2.
Zurück zum Zitat Booth JR, Wood L, Lu D, Houk JC, Bitan T (2007) The role of the basal ganglia and cerebellum in language processing. Brain Res 1133:136–144PubMedCrossRef Booth JR, Wood L, Lu D, Houk JC, Bitan T (2007) The role of the basal ganglia and cerebellum in language processing. Brain Res 1133:136–144PubMedCrossRef
3.
Zurück zum Zitat Braak H, Braak E (1991) Alzheimer’s disease affects limbic nuclei of the thalamus. Acta Neuropathol 81:261–268PubMedCrossRef Braak H, Braak E (1991) Alzheimer’s disease affects limbic nuclei of the thalamus. Acta Neuropathol 81:261–268PubMedCrossRef
4.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef
5.
Zurück zum Zitat Brilliant MJ, Elble RJ, Ghobrial M, Struble RG (1997) The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer’s disease. Neuropathol Appl Neurobiol 23:322–325PubMedCrossRef Brilliant MJ, Elble RJ, Ghobrial M, Struble RG (1997) The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer’s disease. Neuropathol Appl Neurobiol 23:322–325PubMedCrossRef
6.
Zurück zum Zitat Bruen PD, McGeown WJ, Shanks MF, Venneri A (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 131:2455–2463PubMedCrossRef Bruen PD, McGeown WJ, Shanks MF, Venneri A (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 131:2455–2463PubMedCrossRef
7.
Zurück zum Zitat Chen JC, Borson S, Scanlan JM (2000) Stage-specific prevalence of behavioral symptoms in Alzheimer’s disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 8:123–133PubMed Chen JC, Borson S, Scanlan JM (2000) Stage-specific prevalence of behavioral symptoms in Alzheimer’s disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 8:123–133PubMed
8.
Zurück zum Zitat de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, de Bruin PW, Middelkoop HA, van Buchem MA, van der Grond J (2008) Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain 131:3277–3285PubMedCrossRef de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, de Bruin PW, Middelkoop HA, van Buchem MA, van der Grond J (2008) Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain 131:3277–3285PubMedCrossRef
9.
Zurück zum Zitat de Leon MJ, Convit A, DeSanti S, Golomb J, Tarshish C, Rusinek H, Bobinski M, Ince C, Miller DC, Wisniewski HM et al (1995) The hippocampus in aging and Alzheimer’s disease. Neuroimaging Clin North Am 5:1–17 de Leon MJ, Convit A, DeSanti S, Golomb J, Tarshish C, Rusinek H, Bobinski M, Ince C, Miller DC, Wisniewski HM et al (1995) The hippocampus in aging and Alzheimer’s disease. Neuroimaging Clin North Am 5:1–17
10.
Zurück zum Zitat Ellis RJ, Caligiuri M, Galasko D, Thal LJ (1996) Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord 10:103–114PubMedCrossRef Ellis RJ, Caligiuri M, Galasko D, Thal LJ (1996) Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord 10:103–114PubMedCrossRef
11.
Zurück zum Zitat Fennema-Notestine C, Hagler DJ, Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM (2009) Structural MRI biomarkers for preclinical and mild Alzheimer’s disease. Hum Brain Mapp 30: pp 3238–3253 Fennema-Notestine C, Hagler DJ, Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM (2009) Structural MRI biomarkers for preclinical and mild Alzheimer’s disease. Hum Brain Mapp 30: pp 3238–3253
12.
Zurück zum Zitat Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355PubMedCrossRef Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341–355PubMedCrossRef
13.
Zurück zum Zitat Gil Robles S, Gatignol P, Capelle L, Mitchell MC, Duffau H (2005) The role of dominant striatum in language: a study using intraoperative electrical stimulations. J Neurol Neurosurg Psychiatry 76:940–946PubMedCrossRef Gil Robles S, Gatignol P, Capelle L, Mitchell MC, Duffau H (2005) The role of dominant striatum in language: a study using intraoperative electrical stimulations. J Neurol Neurosurg Psychiatry 76:940–946PubMedCrossRef
14.
Zurück zum Zitat Ku HM, Kim JH, Kwon EJ, Kim SJ, Lee HS, Ko HJ, Jo S, Kim DK (2004) A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living(S-IADL). J Korean Neuropsychiatr Assoc 43:189–199 Ku HM, Kim JH, Kwon EJ, Kim SJ, Lee HS, Ko HJ, Jo S, Kim DK (2004) A study on the reliability and validity of Seoul-Instrumental Activities of Daily Living(S-IADL). J Korean Neuropsychiatr Assoc 43:189–199
15.
Zurück zum Zitat Mann DM (1991) The topographic distribution of brain atrophy in Alzheimer’s disease. Acta Neuropathol 83:81–86PubMedCrossRef Mann DM (1991) The topographic distribution of brain atrophy in Alzheimer’s disease. Acta Neuropathol 83:81–86PubMedCrossRef
16.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMed
17.
Zurück zum Zitat Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:167–171PubMedCrossRef Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL (2000) Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 69:167–171PubMedCrossRef
18.
Zurück zum Zitat Newman J (1995) Thalamic contributions to attention and consciousness. Conscious Cogn 4:172–193PubMedCrossRef Newman J (1995) Thalamic contributions to attention and consciousness. Conscious Cogn 4:172–193PubMedCrossRef
19.
Zurück zum Zitat Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M (1989) Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer’s disease. Am J Pathol 134:243–251PubMed Ogomori K, Kitamoto T, Tateishi J, Sato Y, Suetsugu M, Abe M (1989) Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer’s disease. Am J Pathol 134:243–251PubMed
20.
Zurück zum Zitat Packard MG, Knowlton BJ (2002) Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci 25:563–593PubMedCrossRef Packard MG, Knowlton BJ (2002) Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci 25:563–593PubMedCrossRef
21.
Zurück zum Zitat Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D (2005) Behavioral and psychological symptoms in Alzheimer’s disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 19:276–281PubMedCrossRef Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D (2005) Behavioral and psychological symptoms in Alzheimer’s disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 19:276–281PubMedCrossRef
22.
Zurück zum Zitat Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026–1036PubMedCrossRef Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026–1036PubMedCrossRef
23.
Zurück zum Zitat Qiu A, Brown T, Fischl B, Ma J, Miller MI (2010) Atlas generation for subcortical and ventricular structures with its applications in shape analysis. IEEE Trans Image Process 19:1539–1547 Qiu A, Brown T, Fischl B, Ma J, Miller MI (2010) Atlas generation for subcortical and ventricular structures with its applications in shape analysis. IEEE Trans Image Process 19:1539–1547
24.
Zurück zum Zitat Qiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, Mostofsky SH (2009) Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 166:74–82PubMedCrossRef Qiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, Mostofsky SH (2009) Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 166:74–82PubMedCrossRef
25.
Zurück zum Zitat Qiu A, Fennema-Notestine C, Dale AM, Miller MI (2009) Regional shape abnormalities in mild cognitive impairment and Alzheimer’s disease. Neuroimage 40: pp 570–582 Qiu A, Fennema-Notestine C, Dale AM, Miller MI (2009) Regional shape abnormalities in mild cognitive impairment and Alzheimer’s disease. Neuroimage 40: pp 570–582
26.
Zurück zum Zitat Qiu A, Miller MI (2008) Multi-structure network shape analysis via normal surface momentum maps. Neuroimage 42:1430–1438PubMedCrossRef Qiu A, Miller MI (2008) Multi-structure network shape analysis via normal surface momentum maps. Neuroimage 42:1430–1438PubMedCrossRef
27.
Zurück zum Zitat Qiu A, Taylor WD, Zhao Z, MacFall JR, Miller MI, Key CR, Payne ME, Steffens DC, Krishnan KR (2009) APOE related hippocampal shape alteration in geriatric depression. Neuroimage 44:620–626PubMedCrossRef Qiu A, Taylor WD, Zhao Z, MacFall JR, Miller MI, Key CR, Payne ME, Steffens DC, Krishnan KR (2009) APOE related hippocampal shape alteration in geriatric depression. Neuroimage 44:620–626PubMedCrossRef
28.
Zurück zum Zitat Qiu A, Zhong J, Graham S, Chia MY, Sim K (2009) Combined analyses of thalamic volume, shape and white matter integrity in first-episode schizophrenia. Neuroimage 47:1163–1171PubMedCrossRef Qiu A, Zhong J, Graham S, Chia MY, Sim K (2009) Combined analyses of thalamic volume, shape and white matter integrity in first-episode schizophrenia. Neuroimage 47:1163–1171PubMedCrossRef
29.
Zurück zum Zitat Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y (2004) Motor signs during the course of Alzheimer disease. Neurology 63:975–982PubMed Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J, Albert M, Marder K, Bell K, Honig LS, Wegesin D, Stern Y (2004) Motor signs during the course of Alzheimer disease. Neurology 63:975–982PubMed
30.
Zurück zum Zitat Selden N, Mesulam MM, Geula C (1994) Human striatum: the distribution of neurofibrillary tangles in Alzheimer’s disease. Brain Res 648:327–331PubMedCrossRef Selden N, Mesulam MM, Geula C (1994) Human striatum: the distribution of neurofibrillary tangles in Alzheimer’s disease. Brain Res 648:327–331PubMedCrossRef
31.
Zurück zum Zitat Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97PubMedCrossRef Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87–97PubMedCrossRef
32.
Zurück zum Zitat Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008) Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 70:1836–1841PubMedCrossRef Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM (2008) Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 70:1836–1841PubMedCrossRef
33.
Zurück zum Zitat Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
34.
Zurück zum Zitat Van der Werf YD, Witter MP, Uylings HB, Jolles J (2000) Neuropsychology of infarctions in the thalamus: a review. Neuropsychologia 38:613–627PubMedCrossRef Van der Werf YD, Witter MP, Uylings HB, Jolles J (2000) Neuropsychology of infarctions in the thalamus: a review. Neuropsychologia 38:613–627PubMedCrossRef
Metadaten
Titel
Volume reduction in subcortical regions according to severity of Alzheimer’s disease
verfasst von
Jee Hoon Roh
Anqi Qiu
Sang Won Seo
Hock Wei Soon
Jong Hun Kim
Geon Ha Kim
Min-Jeong Kim
Jong-Min Lee
Duk L. Na
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 6/2011
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-010-5872-1

Weitere Artikel der Ausgabe 6/2011

Journal of Neurology 6/2011 Zur Ausgabe

Pioneers in Neurology

Charles Bell (1774–1842)

Letter to the Editors

Isolated ring-finger myoclonus

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.